Opaleye Management as of Dec. 31, 2021
Portfolio Holdings for Opaleye Management
Opaleye Management holds 39 positions in its portfolio as reported in the December 2021 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Codexis (CDXS) | 8.9 | $42M | 1.3M | 31.27 | |
| Ocular Therapeutix (OCUL) | 8.8 | $42M | 6.0M | 6.97 | |
| Chimerix (CMRX) | 7.6 | $36M | 5.6M | 6.43 | |
| Celldex Therapeutics Com New (CLDX) | 6.9 | $33M | 844k | 38.64 | |
| Harrow Health (HROW) | 6.0 | $28M | 3.3M | 8.64 | |
| Cytokinetics Com New (CYTK) | 5.6 | $26M | 580k | 45.58 | |
| Crinetics Pharmaceuticals In (CRNX) | 4.4 | $21M | 724k | 28.41 | |
| Protara Therapeutics Com Stk (TARA) | 3.8 | $18M | 2.7M | 6.79 | |
| Semler Scientific (SMLR) | 3.3 | $16M | 172k | 91.65 | |
| Stereotaxis Com New (STXS) | 3.3 | $16M | 2.5M | 6.20 | |
| Keros Therapeutics (KROS) | 3.3 | $16M | 266k | 58.51 | |
| Kiniksa Pharmaceuticals Com Cl A (KNSA) | 2.6 | $12M | 1.0M | 11.77 | |
| Protagonist Therapeutics (PTGX) | 2.5 | $12M | 342k | 34.20 | |
| Proqr Therapeutics Nv Shs Euro (PRQR) | 2.4 | $12M | 1.4M | 8.01 | |
| Eton Pharmaceuticals (ETON) | 2.2 | $10M | 2.4M | 4.29 | |
| Sutro Biopharma (STRO) | 2.1 | $10M | 680k | 14.88 | |
| Merus N V (MRUS) | 2.1 | $10M | 318k | 31.80 | |
| Larimar Therapeutics (LRMR) | 2.0 | $9.5M | 884k | 10.79 | |
| Fortress Biotech | 2.0 | $9.4M | 3.8M | 2.50 | |
| Reata Pharmaceuticals Class A | 1.8 | $8.7M | 330k | 26.37 | |
| Tracon Pharmaceuticals Com New (TCON) | 1.8 | $8.5M | 3.1M | 2.77 | |
| Ginkgo Bioworks Holdings Class A Shares (DNA) | 1.6 | $7.7M | 930k | 8.31 | |
| Vaxcyte (PCVX) | 1.6 | $7.5M | 316k | 23.79 | |
| Macrogenics (MGNX) | 1.6 | $7.4M | 462k | 16.05 | |
| Xoma Corp Del Com New (XOMA) | 1.5 | $7.1M | 338k | 20.85 | |
| Tela Bio (TELA) | 1.2 | $5.8M | 450k | 12.80 | |
| Hyperfine Com Cl A (HYPR) | 1.2 | $5.5M | 763k | 7.24 | |
| Bridgebio Pharma (BBIO) | 1.2 | $5.5M | 328k | 16.68 | |
| Neoleukin Therapeutics | 1.1 | $5.0M | 1.0M | 4.82 | |
| 4d Molecular Therapeutics In (FDMT) | 1.1 | $5.0M | 229k | 21.94 | |
| Verastem | 1.0 | $4.8M | 2.3M | 2.05 | |
| Sierra Oncology Com New | 0.8 | $3.6M | 166k | 21.74 | |
| Mei Pharma Com New | 0.7 | $3.5M | 1.3M | 2.67 | |
| Nucana Sponsored Adr (NCNA) | 0.6 | $2.8M | 1.2M | 2.38 | |
| Avalo Therapeutics | 0.5 | $2.5M | 1.5M | 1.70 | |
| Synlogic | 0.4 | $2.1M | 850k | 2.42 | |
| Aveo Biosciences Com New | 0.3 | $1.2M | 263k | 4.69 | |
| Liquidia Corporation Com New (LQDA) | 0.0 | $82k | 17k | 4.88 | |
| Biolinerx Sponsored Ads (BLRX) | 0.0 | $34k | 17k | 2.04 |
